Andrea’s Blog

Decentralized clinical trials

A framework for “direct-to-patient,” “remote,” “site-less,” and…

Twitter’s design flaw that stunts healthy, civil, productive conversations

Last month, the Twitterverse stumbled upon an all-too-common situation that is worth discussing in more than 280 characters. Deleting a Tweet is the deficient but only available option to stop the viral…

Going Viral: New Responsibilities in The Attention Economy

In the arms-race for attention, our online communication platforms employ nudges, notifications, and other tools to change our behavior and increase our “engagement.” Like drugs, algorithms also have (unintended) side-effects —…

[Reflection] The USA: Now with more dystopia

Instead of taking an Uber/Lyft this afternoon, I decided to walk a few miles…

Dapps 101: How do I start developing on Ethereum?

Myth Busting: Can a blockchain save healthcare?

Software-Enabled Clinical Trials

Today, only 5% of the US population participates in clinical research. With the rise of new software tools that make research faster, cheaper, and more accessible and with a forward-looking FDA digital health team, the time is ripe for a clinical trial paradigm shift.

TIL: Why Harvard Business School stubbornly holds on to the Case Method